Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Barrett Esophagus × Bevacizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 51 Carcinoma, Non-Small-Cell Lung 26 Breast Neoplasms 17 Ovarian Neoplasms 13 Rectal Neoplasms 12 Neoplasm Metastasis 9 Glioblastoma 9 Carcinoma, Hepatocellular 9 Colonic Neoplasms 8 Carcinoma, Renal Cell 7 Uterine Cervical Neoplasms 6 Fallopian Tube Neoplasms 5 Brain Neoplasms 5 Triple Negative Breast Neoplasms 4 Nasopharyngeal Carcinoma 4 Stomach Neoplasms 3 Recurrence 3 Pleural Effusion, Malignant 3 Neoplasms 3 Meningeal Carcinomatosis 3 Melanoma 3 Lung Neoplasms 3 Kidney Neoplasms 3 Colorectal Cancer Metastatic 3 Non-squamous Non-small Cell Lung Cancer 2 Non-small Cell Lung Cancer Metastatic 2 Liver Neoplasms 2 Liver Metastasis Colon Cancer 2 Intestinal Neoplasms 2 Inflammatory Breast Neoplasms 2

Interventions

Endoscopic Mucosal Resection 4 Endoscopy, Digestive System 3 Endoscopy 2 Biopsy 2 gluconic acid 1 Surveys and Questionnaires 1 Spectrum Analysis 1 Radiofrequency Ablation 1 Rabeprazole 1 Proton Pump Inhibitors 1 Proflavine 1 Narrow Band Imaging 1 Lansoprazole 1 High-Throughput Screening Assays 1 Genetic Linkage 1 Gastroscopy 1 Esomeprazole 1 Erlotinib Hydrochloride 1 Diet, Gluten-Free 1 Decision Support Techniques 1 Cryotherapy 1 Comparative Genomic Hybridization 1 Cetuximab 1 Breath Tests 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05745857 2023-02-27

SLURP

University Medical Center Groningen

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡